Extracorporeal Photopheresis (ECP) has been recognised by the scientific community as a therapeutic option to treat various disorders, such as:

  • Cutaneous T-cell lymphoma (Sezary syndrome)
  • GVHD (acute and chronic)
  • Solid organ transplant rejection

Macopharma has developed a complete product range for the off-line extracorporeal photpheresis technique.

Extracorporeal photopheresis (ECP) is based on the exposure of peripheral blood mononuclear cells to the photosensitizing agent (8-methoxypsoralen or 8-MOP) and UVA irradiation. Mononuclear cells are harvested by an apheresis device usually and reinfused to the patient after cell irradiation.


Get a Quote

Request A Quote